Vesta McDowell, DPM
Foot Surgery · Bowie, MDNPI 1639145147
Payments from drug & device makers
What this record shows
This record is dominated by other: $36,400 of the $39,307 with a category attached, or 92.6%. Convatec Inc. accounts for 92.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $36,531 and has fallen 99.9% since, to $47 in 2025. Among foot surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $714.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$36K
- Triad Life Sciences Inc.$2K
- Paratek Pharmaceuticals, Inc.$344
- Smith+Nephew$337
- Organogenesis Inc.$205
- Abbott$149
- plus $223 from 8 others
What the payments were for
- Travel & lodging$1,1713%
- Food & beverage$1,7354%
- Other$36,40093%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 5 | $36,400 |
| Triad Life Sciences Inc. | 8 | $1,649 |
| Paratek Pharmaceuticals, Inc. | 14 | $344 |
| Smith+Nephew | 9 | $337 |
| Organogenesis Inc. | 8 | $205 |
| Abbott | 1 | $149 |
| Sebela Pharmaceuticals Inc. | 2 | $50 |
| Tactile Systems Technology Inc | 1 | $45 |
| Melinta Therapeutics, LLC | 2 | $41 |
| Stryker | 1 | $32 |
| Merck | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$37,826
- Supera peripheral stent system$149
- NUZYRA$125
- Santyl$119
- REGRANEX$119
- Oasis$119
How this compares
$39,307 in reported general payments places this provider in the 90th percentile of 28 foot surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 34 | $1,310 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Bowie
- Jacob WynesBaltimore$214K
- Herman ZarateTakoma Park$57K
- Kiana TrentBaltimore$8K
- Ronald ShermanBaltimore$7K
- Aaron LewisLandover$3K
- Johny MotranHyattsville$3K
- Neil OhoraOlney$2K
- Mitchell BarberLaurel$1K
- Mark LevyRockville$1K
- Darlyne CangeGlen Burnie$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.